SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-17-000644
Filing Date
2017-01-13
Accepted
2017-01-13 15:03:52
Documents
1
Group Members
PIONEER PHARMA (HONG KONG) CO LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A cpph20170112_sc13da.htm SC 13D/A 112071
  Complete submission text file 0001437749-17-000644.txt   113627
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 17527598
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 ELGIN AVENUE, GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE, GEORGE TOWN GRAND CAYMAN E9 KY1-9005 86-21-50498982
China Pioneer Pharma Holdings Ltd (Filed by) CIK: 0001593299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A